C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2006
10/19/2006	US20060233824 Staphylococcal protein specific immunoglobulin for use in prevention and treatment of microorganismal infection
10/19/2006	US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/19/2006	US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
10/19/2006	US20060233821 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
10/19/2006	US20060233820 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection
10/19/2006	US20060233819 Inhibition of T cell activation by butyrophilin 4 or B7-L1
10/19/2006	US20060233818 Organic compounds
10/19/2006	US20060233817 Peptide-based immunization therapy for treatment of atherosclerosis
10/19/2006	US20060233816 Use of plant oil-bodies in vaccine delivery systems
10/19/2006	US20060233813 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
10/19/2006	US20060233808 Peptabody for cancer treatment
10/19/2006	US20060233806 Removal promoters and inhibitor for apoptosis cells in vivo
10/19/2006	US20060233804 IGF antagonist peptides
10/19/2006	US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis
10/19/2006	US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
10/19/2006	US20060233796 Method of modulating memory effector T-cells and compositions
10/19/2006	US20060233792 novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
10/19/2006	US20060233788 Anti-ghrelin antibodies
10/19/2006	US20060233785 Immunointeractive molecules and uses thereof
10/19/2006	US20060233779 Ring finger family proteins and uses related thereto
10/19/2006	US20060233770 a human cell line, which lacks major histocompatibility class I (MHC-I) and class II (MHC-II) antigens, has been modified to comprise and express a nucleotide sequence encoding an immunomodulator, and a nucleotide sequence encoding an antigen of Epstein-Barr virus
10/19/2006	US20060233755 A virus envelope vector encapsulating a hepatocyte growth factor (HGF) gene or its plasmid as an active ingredient; gene therapy for the prevention and treatment of deafness
10/19/2006	US20060233753 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs
10/19/2006	US20060233749 Interleukin-19
10/19/2006	US20060233747 Polymer-modified synthetic proteins
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA
10/19/2006	US20060233742 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN
10/19/2006	US20060233708 Peptide antagonists of TGF-beta family members and therapeutic uses thereof
10/19/2006	US20060233706 Marked peptides having affinity for a phospholipid and uses
10/19/2006	DE102005016230A1 Vorrichtung zur Trockenvernebelung Apparatus for dry nebulization
10/19/2006	DE102005014844A1 Use of hydrophobin for treating soil-repellent of hard surface e.g. tiles, floors, armatures, wash basin, showering tubs, bath tubs, toilets, shower cubicles, bathroom furniture, furniture, mirrors, table-ware, cutlery and glasses
10/19/2006	DE102005014843A1 Use of hydrophobin for treating surfaces such as hardened mineral building materials, natural stones, artificial stones or ceramics
10/19/2006	DE10083676B4 Rekombinantes Enzym mit ausgezeichneter D-Aminosäureoxidaseaktivität sowie dessen Herstellung The recombinant enzyme with excellent D-Aminosäureoxidaseaktivität and its production
10/19/2006	CA2604538A1 Hiv vaccine
10/19/2006	CA2604536A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006	CA2604442A1 Pharmaceutical compositions for and methods of inhibiting hcv replication
10/19/2006	CA2604299A1 Modified coagulation factor viii with enhanced stability and its derivates
10/19/2006	CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use
10/19/2006	CA2603863A1 Gammaretrovirus associated with cancer
10/19/2006	CA2603850A1 Polymyxin b analogs for lps detoxification
10/19/2006	CA2603779A1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
10/19/2006	CA2603083A1 Human protooncogene and protein encoded by same
10/19/2006	CA2603066A1 Human protooncogene trg and protein encoded therein
10/19/2006	CA2602976A1 Human cancer suppressor gene, protein encoded therein
10/19/2006	CA2600291A1 Peptide synthesis of alpha-helixes on peg resin
10/19/2006	CA2597789A1 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
10/19/2006	CA2587848A1 Antiinfective lipopeptides
10/19/2006	CA2583027A1 Serum-free cell culture medium for mammalian cells
10/18/2006	EP1712632A2 Gene for a heat resistant enzymes of the amino acid biosynthetic pathway derived from thermophilic Coryneform bacteria
10/18/2006	EP1712631A2 Fc receptors and polypeptides
10/18/2006	EP1712629A2 Compounds and methods for diagnosis of tuberculosis
10/18/2006	EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006	EP1712625A1 An arabidopis thaliana transcription factoras well as the encoding gene and the use thereof
10/18/2006	EP1712623A2 Selection of proteins using RNA-protein fusions
10/18/2006	EP1712621A1 Gene markers linked to fusarium head blight-resistance factor and utilization thereof
10/18/2006	EP1712620A1 Peptide originating in epidermal growth factor receptor (egfr)
10/18/2006	EP1712619A1 Preventive/remedy for cancer
10/18/2006	EP1712562A1 Process for purification of hemoglobin
10/18/2006	EP1712561A1 Silk thread containing spider thread protein and silkworm producing the silk thread
10/18/2006	EP1712560A1 Hypoallergenic proteins derived from the major allergen of parietaria judaica
10/18/2006	EP1712559A1 Polymyxin B analogs for LPS detoxification
10/18/2006	EP1712558A1 Method for separating/refining cationic protein
10/18/2006	EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006	EP1712237A2 Erythropoietin solution preparation stabilized with leucine, glutamic acid or lysine
10/18/2006	EP1712223A1 Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer
10/18/2006	EP1712125A1 DISEASE MODEL ANIMAL EXPRESSING MEGSIN/RAGE/iNOS AND METHOD OF EVALUATING COMPOUND WITH THE USE OF THE ANIMAL
10/18/2006	EP1711834A2 Process for screening glycoform-specific antibodies
10/18/2006	EP1711635A1 Genes associated with canine osteoarthritis and related methods and compositions
10/18/2006	EP1711629A1 Method for detecting the risk of cardiovascular diseases such as acute myocardial infarction and coronary heart disease by analysing defensin
10/18/2006	EP1711614A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
10/18/2006	EP1711611A2 Selection markers useful for heterologous protein expression
10/18/2006	EP1711610A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY
10/18/2006	EP1711609A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
10/18/2006	EP1711608A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient
10/18/2006	EP1711605A1 Eosinophil-deficient transgenic animals
10/18/2006	EP1711604A1 Diabetogenic epitopes
10/18/2006	EP1711603A1 Transformed saccharomyces cerevisiae and method for mass-production of lk8 protein using the same
10/18/2006	EP1711592A2 Cell cycle genes and related methods of using
10/18/2006	EP1711533A2 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
10/18/2006	EP1711532A2 Combined use of a glp-1 agonist and gastrin compounds
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711530A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
10/18/2006	EP1711526A2 Treatment of viral infections
10/18/2006	EP1711525A2 Neoplasm-specific polypeptides and their uses
10/18/2006	EP1711524A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
10/18/2006	EP1711523A1 Analogues of glp-1
10/18/2006	EP1711522A2 Antiviral compositions which inhibit paramyxovirus infection
10/18/2006	EP1711521A1 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
10/18/2006	EP1711520A1 Polypeptides for the diagnosis and therapy of leishmaniasis
10/18/2006	EP1711519A1 Proteins inducing multiple resistance of plants to phytopathogens and pests
10/18/2006	EP1711518A2 Chimpanzee adenovirus vaccine carriers
10/18/2006	EP1711517A2 MUTANT SODIUM CHANNEL NAv1.7 AND METHODS RELATED THERETO
10/18/2006	EP1711516A1 Hcv rna-dependent rna polymerase
10/18/2006	EP1711515A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/18/2006	EP1711513A2 Nanofiltration of factor vii solutions to remove virus
10/18/2006	EP1711511A1 Method for crystallization of proteins using polysaccharides
10/18/2006	EP1711483A2 A method for manufacturing optically pure coumaryl amino acid salts and the coumaryl amino acid salts thus obtained
10/18/2006	EP1711198A2 Methods and compositons for treating cancer
10/18/2006	EP1711196A2 Inhibitors of type 2 vascular endothelial growth factor receptors

1 ... 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 ... 2916